Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed5
Terminated1

Role Distribution

Principal Investigator2
Other Roles4
PI Rate33%

Activity Timeline

Clinical Trials (6)

NCT04332276Phase 1/2Completed
Dopaminergic restauratIon by intraVEntriculaire Administration
Parkinson Disease
StudychairStart date: 2020-09-18
NCT02655315Phase 2Completed
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
Parkinson Disease
StudychairStart date: 2016-02-09
NCT02360891Completed
Study of Predictive Factors of Progression of Motor Neurone Disease
Amyotrophic Lateral SclerosisMotor Neuron Disease
StudychairStart date: 2015-01-12
NCT02360683Completed
Predictive Factors and Subthalamic Stimulation in Parkinson's Disease
Parkinson's Disease
StudychairStart date: 2013-11-18
NCT02883712Terminated
Study of Predictors of Response to Anti Epilepsy in Epilepsy
Seizure
PrincipalinvestigatorStart date: 2013-05-21
NCT02880033Not ApplicableCompleted
Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes
Amyotrophic Lateral SclerosisIron OverloadOxidative Stress+1 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisParkinson DiseaseMotor Neuron Disease
Similarity Score15%

Caroline Moreau, MD,PhD

University Hospital, Lille

Related
2 trials

Shared therapeutic areas:

Parkinson Disease

Worked with same sponsors:

InBrain PharmaUniversity Hospital, Lille
Collaborated on 1 trial
Similarity Score14%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisParkinson Disease
Similarity Score10%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisParkinson Disease
Similarity Score10%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisParkinson Disease
Similarity Score10%

Rangashetti Srinivasa, MD

M.S. Ramaiah Memoria Hospital, Bangalore

Related
1 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score5%

Chandrashekhar Meshram, MD

Brain and Mind Institute, Nagpur

Related
1 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score5%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score5%

Nellikunja Shankar, MD

Mallikatta Neuro and Research Centre, Mangalore

Related
1 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score5%

Sunil Bandishti, MD

Ruby Hall Clinic, Pune

Related
1 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04332276Phase 1/2StudyChair

Dopaminergic restauratIon by intraVEntriculaire Administration

Parkinson Disease
Completed
NCT02655315Phase 2StudyChair

Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease

Parkinson Disease
Completed
NCT02360891StudyChair

Study of Predictive Factors of Progression of Motor Neurone Disease

Amyotrophic Lateral SclerosisMotor Neuron Disease
Completed
NCT02360683StudyChair

Predictive Factors and Subthalamic Stimulation in Parkinson's Disease

Parkinson's Disease
Completed
NCT02883712PrincipalInvestigator

Study of Predictors of Response to Anti Epilepsy in Epilepsy

Seizure
Terminated
NCT02880033Not ApplicablePrincipalInvestigator

Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes

Amyotrophic Lateral SclerosisIron OverloadOxidative Stress+1 more
Completed

All 6 trials loaded